Shelf life determination based on equivalence assessment

Journal of Biopharmaceutical Statistics

Volumn 13, Issue 3, 2003, Pages 431-449

  Tsong, Yi ^a   Chen, Wen Jen ^a   Lin, Tsae Yun Daphne ^a   Chen, Chi Wan ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Equivalence test; Linear regression; Shelf life testing; Stability pooling test

Indexed keywords

ACCURACY; ANALYSIS OF COVARIANCE; ARTICLE; DATA ANALYSIS; DECISION MAKING; DRUG STABILITY; EQUIVALENCE TEST; HYPOTHESIS; LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; SHELF LIFE; STATISTICAL ANALYSIS;

CONFIDENCE INTERVALS; DRUG STABILITY; DRUG STORAGE; MODELS, STATISTICAL; TIME FACTORS;

EID: 0042635607     PISSN: 10543406     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIP-120022765     Document Type: Article

References (22)

1. Asano, C. (1960). Tests due to pooling data through preliminary test on biological direct assay. Bull. Math. Stat. 9:25-39.
2. Bancroft, T. A. (1944). On biases in estimation due to the use of preliminary tests of significance. Annal Math. Stat. 15:190-204.
3. Bancroft, T. A. (1964). Analysis and inference for incompletely specified models involving the use of preliminary tests of significance. Biometrics 20(3):427-442.
4. Chen, W. J., Tsong, Y. (2003). Significance level for stability polling test: a simulation study. J. Biopharm. Stat. 13(3):355-374.
5. Chen, J. J., Hwang, J.-S., Tsong, Y. (1995). Estimation of the shelf-life of drugs with mixed effects models. J. Biopharm. Stat. 5(1):131-140.
6. Chow, S. C., Liu, J. P. (1995). Statistical Design and Analysis in Pharmaceutical Sciences. New York, NY USA: Marcel Dekker.
7. Draft ICH Consensus Guideline. (2001a). Q1E Stability Data Evaluation. Food and Drug Administration, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research, www.fda.gov/cder/guidance/4983dft.pdf.
8. FDA. (1987). Guidelines for Submitting Documentation for the Stability of Human Drugs and Biologics. Rockville MD: USA Food and Drug Administration, Center for Drugs and Biologics.
9. Guidance for Industry: ICH, (2001b). Q1A(R) Stability Testing of New Drug Substances and Products. Food and Drug Administration, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research, www.fda.gov/cder/guidance/4282fnl.pdf.
10. Guidance for Industry: ICH, (2003). Q1D Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products. Food and Drug Administration, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research, www.fda.gov/cder/guidance/4985fnl.pdf.
11. Johnson, J. P., Bancroft, T. A., Han, C. P. (1977). A pooling methodology for regressions in prediction. Biometrics 33:57-67.
12. Krutchoff, R. G. (1967). Classical and inverse regression methods of calibration. Technometrics 9:425-439.
13. Larson, H. J., Bancroft, T. A. (1963). Sequential model building for prediction in regression analysis I. Annal Math. Stat. 34:231-242.
14. Lin, T.-Y.D., Tsong, Y. (1991). Determination of significance level for pooling data in stability studies. Proceedings of Biopharm. Section of Joint Statist. Meeting, Am. Stat. Assoc. 195-201.
15. Lin, K. K., Lin, T. D., Kelly, R. E. (1993). Stability of drugs. In: Buncher, C. R., Tsay, J. Y., eds. Statistics in the Pharmaceutical Industry. 2nd ed. New York, NY, USA: Marcel Dekker, pp. 419-444.
16. Ruberg, S. J., Hsu, J. C. (1990). Multiple comparison procedures for pooling batches in stability studies. Proc. Biopharm. Sec. Joint Stat. Meeting, Am. Stat. Assoc. 204-209.
17. Ruberg, S. J., Stegemen, J. W. (1991). Pooling data from stability studies: testing the equality of batch degradation slopes. Biometrics 47:1059-1069.
18. Schuirmann, D. J. (1987). A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J. Pharm. Biopharm. 15:657-680.
19. Tsong, Y., Chen, W. J., Chen, C. W. (2003). Statistical analysis of multiple factor design of stability study. J. Biopharm. Stat. 13(3):376-393.
20. Yoshioka, S., Aso, Y., Kojima, S. (1996a). Statistical evaluation of shelf-life of pharmaceutical products estimated by matrixing. Drug Stab. 1:147-151.
21. Yoshioka, S., Aso, Y., Kojima, S., Po, A. L. W. (1996b). Power of analysis of variance for assessing batch-variation of stability data of pharmaceuticals. Chem. Pharm. Bull. 44(10):1948-1950.
22. Yoshioka, S., Aso, Y., Kojima, S. (1997). Assessment of shelf-life equivalence of pharmaceutical products. Chem. Pharm. Bull. 45(9):1482-1484.